Form 8-K - Current report:
SEC Accession No. 0001562762-24-000094
Filing Date
2024-04-19
Accepted
2024-04-19 16:06:53
Documents
14
Period of Report
2024-04-19
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 8k20240419.htm   iXBRL 8-K 39480
2 EX-99.1 exhibit991.htm EX-99.1 39557
  Complete submission text file 0001562762-24-000094.txt   207590

Data Files

Seq Description Document Type Size
3 EX-101.SCH vaxx-20240419.xsd EX-101.SCH 1848
4 EX-101.LAB vaxx-20240419_lab.xml EX-101.LAB 15603
5 EX-101.PRE vaxx-20240419_pre.xml EX-101.PRE 11205
18 EXTRACTED XBRL INSTANCE DOCUMENT 8k20240419_htm.xml XML 4170
Mailing Address 505 ODYSSEY WAY EXPLORATION PARK FL 32953
Business Address 505 ODYSSEY WAY EXPLORATION PARK FL 32953 (254) 244-5739
Vaxxinity, Inc. (Filer) CIK: 0001851657 (see all company filings)

EIN.: 862083865 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41058 | Film No.: 24857795
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)